1 Year of Treatment With Canakinumab in Behçet's Disease Patients With Neurologic or Vascular Involvement
Clinical trial NCT02756650 · COMPLETED
Trial details
- NCT number
- NCT02756650
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-06-23
- Primary completion
- 2019-01-31
- Enrollment
- 8
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.